Skip to main content
OpenTrials

Clinical trial condition

Post-Polycythemia Vera

Explore clinical trials studying Post-Polycythemia Vera. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Post-Polycythemia Vera trial results

Completed

An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib

NCT03952039

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Local Institution - 103 Darlinghurst, New South Wales, Australia
  • Local Institution - 101 Adelaide, South Australia, Australia
  • Local Institution - 105 Box Hill, Victoria, Australia
  • Local Institution - 102 Langwarrin, Victoria, Australia
View all 107 locations
View Trial Details
Completed

Safety Study Evaluating Twice-Daily Administration of Momelotinib in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis

NCT01423058

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • MD Anderson Cancer Center, The University of Texas Houston, Texas, United States
  • Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
View Trial Details

Related conditions